Where does Mighty Oak Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mighty Oak Medical, Inc. ranks #11,733 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mighty Oak Medical, Inc. hold?

Mighty Oak Medical, Inc. holds 26 US utility patents granted between 2017 and 2025, spanning 6 technology areas.

What is Mighty Oak Medical, Inc.'s Innovation Score?

Mighty Oak Medical, Inc. has an Innovation Score of 37.6 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Mighty Oak Medical, Inc. focus on?

Mighty Oak Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 18 patents, ranking #990 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Mighty Oak Medical, Inc.'s patent grant rate increasing or decreasing?

Mighty Oak Medical, Inc.'s recent grant velocity is +129% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Mighty Oak Medical, Inc.'s patents?

Mighty Oak Medical, Inc.'s patents average 15.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mighty Oak Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mighty Oak Medical, Inc.

USPTO PatentsView assignee record - 26 granted patents across 6 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mighty ranks #11,733 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 6 technology areas.

#11,733
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.6/100): 15.3
avg claims per patent: +129%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11733 · US Corporation #11,733 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,733/49,997
PHOTO-FINISH Mauser Werke
CPC-NARROW A61B · 6 areas
INNOV-THIN 37.6/100
CLAIMS-RICH 15.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +129% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mauser Werke GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mighty’s 37.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (30%) Velocity 8.3 pts (22%) Breadth 8.7 pts (23%) Claim depth 9.2 pts (24%)

Qualcomm Incorporated · highest

85
Novo Nordisk Health… · near

38
ShenZhen Goldsun… · near

38
Jarllytec · near

38
Mighty Oak Medical · this assignee

38
Tactus Technology · near

38
3D Lighting… · lowest

7

What this shows Mighty's Innovation Score is 37.6/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Mighty?

Each dot is one of Mighty’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mighty’s own 15.3 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Mighty vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mighty's grants concentrate

Mighty Oak Medical, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 69.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2021. By volume, Mighty sits between Mauser Werke GmbH and NEC Communication Systems, Ltd..

Mighty's three-year grant acceleration

Mighty Oak Medical, Inc. shows 10 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Mauser Werke

26
Max-delbrück-cent…

26
Medlumics S L

26
Metal Fusion

26
Monolith Materials

26
Monrovia Nursery

26
Nagrastar

26
NEC Communication…

26
Mighty Oak Medical ◀

26

What this shows Mighty holds 26 patents at rank #11,738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mighty

By rank, the assignees closest to #11,738 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Mighty's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mighty, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Mighty ranks #990 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Jarllytec Co., Ltd. 38 Tactus Technology, Inc. 38 Novo Nordisk Health Care AG 38 ShenZhen Goldsun Network Intelligence Technology Co., Ltd. 38

Mighty's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Mighty Oak Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	7.7%
2018	3	11.5%
2019	2	7.7%
2020	5	19.2%
2021	1	3.8%
2022	5	19.2%
2023	3	11.5%
2024	2	7.7%
2025partial year	3	11.5%

Which technologies does Mighty Oak Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 18

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 9

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 7

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 2

G01T - Measurement OF Nuclear OR X-radiation 2

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Mighty Oak Medical, Inc.'s patent record in context - here's where to go next.

Mighty Oak Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 69.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #11,733 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mighty Oak Medical, Inc. against Mauser Werke GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.